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Abstract
The fate of doxycycline (DC), a second generation tetracycline antibiotic, in the environment has drawn increasing attention in recent years due to its wide usage. Little is
known about the biodegradability of DC in the environment. The objective of this study
was to characterize the biotransformation of DC by pure bacterial strains with respect
to reaction kinetics under different environmental conditions and biotransformation
products. Two bacterial strains, Brevundimonas naejangsanensis DD1 and Sphingobacterium mizutaii DD2, were isolated from chicken litter and characterized for their biotransformation capability of DC. Results show both strains rely on cometabolism to
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biotransform DC with tryptone as primary growth substrate. DD2 had higher biotransformation kinetics than DD1. The two strains prefer similar pHs (7 and 8) and temperature (30 °C), however, they exhibited opposite responses to increasing background
tryptone concentration. While hydrolysis converted DC to its isomer or epimer, the two
bacterial strains converted DC to various biotransformation products through a series
of demethylation, dehydration, decarbonylation and deamination. Findings from the
study can be used to better predict the fate of DC in the environment.
Keywords: Doxycycline, Biotransformation, Kinetic, Transformation products

1. Introduction
Doxycycline (DC) is a second generation tetracycline antibiotic synthesized by deoxygenating the C6 position of oxytetracycline (Nogueira et
al., 2011; Das et al., 2019). Compared to the first generation tetracycline antibiotics, DC (C22H24N2O8, 444.44 g mol–1 (Borghi et al., 2015;
Fan et al., 2019)) is a safer alternative (Heaton et al., 2007), because it is
more lipid soluble (Szatmari et al., 2012) (3–5 times higher lipophilicity
(Spina-Cruz et al., 2019; Agwuh and MacGowan, 2006)) and has higher
bioavailability, shorter half-life, stronger antibacterial potency (Yan et
al., 2018), and lower toxicity (Ponnampalam, 1981; Russell et al., 1996).
Because of these traits, DC is the most commonly used tetracycline antibiotic in China (Zhang et al., 2015) and has been frequently used on
livestock (Widyasari-Mehta et al., 2016) and in human medicine (Markowska et al., 2019; Grant et al., 2019). Exposure to DC could have transient effects on biomass and nitrate formation, reduce the number of
earthworm juveniles, and exert negative effects on the seedling growth
of tomato (Litskas et al., 2019).
With the increasing use, DC has been detected in various urban and
agricultural environments (Daghrir and Drogui, 2013). For example, DC
residual concentrations were 64–915 ng L–1 and 1.3–1.5 mg kg–1 in the final effluent and sludge, respectively, of municipal wastewater treatment
plants in Sweden (Lindberg et al., 2005). DC was detected at 0–191 ng
L–1 and 0–39 ng L–1 in reclaimed water and groundwater, respectively, in
15 cities in China (Ma et al., 2015), as well as up to 82 ng L–1 in surface
water (Deng et al., 2016). In the Rio Grande River between the United
States and Mexico, DC concentrations ranged at 76.73–130.79 ng L–1 in
water and at 0.23–0.32 ng g–1 in the sediment (Fuentes et al., 2019). In
agricultural environment, DC was detected at 78.5 mg kg–1 dry weight in

H e e t a l . i n J o u r n a l o f H a z a r d o u s M at e r i a l s 4 1 1 ( 2 0 2 1 )

3

broiler chicken litter and 63–728 μg kg–1 in litter-amended soil following
land application (Ho et al., 2014). The degradation of tetracycline antibiotics in the environmental depends on both the properties of individual
antibiotic compound (e.g., water solubility, molecular structure, etc.) and
the environmental conditions (e.g., soil type, light, temperature, microbial biomass, etc.) (Zaranyika et al., 2015). Tetracyclines can be removed
via hydrolysis, photolysis, oxidation and biodegradation (Li and Zhang,
2010; Gothwal and Shashidhar, 2015; Dai et al., 2019). Known degradation mechanisms of DC include hydrolysis (Zaranyika et al., 2015), photocatalytic (Wang et al., 2019; Tong et al., 2019; Adamek et al., 2016;
Liu et al., 2018; Bolobajev et al., 2016), adsorption (Fan et al., 2019; Liu
et al., 2017, 2019; Wei et al., 2019; Chao et al., 2014; Brigante and Avena, 2016; Zhang et al., 2016), and advanced oxidation (Spina-Cruz et
al., 2019; Bolobajev et al., 2016; Zhang et al., 2016). The half-lives of DC
are reported to be between 4.5 days and 76.3 days under various environmental conditions (Szatmari et al., 2012; Zaranyika et al., 2015).
Compared to physiochemical processes, much less is known about the
biotransformation of DC. One study isolated ten DC degrading bacterial
strains from a vegetable field that received manure application for years
(Wen et al., 2018). It is unclear how environmental conditions affect microbial transformation of DC and what biotransformation products may
form as a result of microbial activities.
The objective of this study was to characterize the biotransformation of DC by pure bacterial strains with respect to reaction kinetics under different environmental conditions and biotransformation products.
In this study, two bacterial strains capable of co-metabolizing DC were
isolated from soil. The biotransformation of DC by these two strains
were characterized under multiple environmental conditions, such as
pH, temperature, and background nutrient condition. Furthermore, the
biotransformation productions of DC were characterized for the two
strains, and presumptive biotransformation pathways were proposed.
The use of pure cultures in this study enabled us to systematically investigate how environmental conditions may affect DC biotransformation. Because poultry facilities are a major user of DC, the pure cultures
isolated from chicken litter in this study can increase our knowledge on
DC biotransformation and improve our ability to predict the fate of DC
in the environment such as those under the influence of DC contaminated animal wastes.
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2. Materials and methods
2.1. Chemicals
Reagent grade chemicals were used in the study, Lysogeny broth (LB)
medium was made of 10 g L–1 tryptone, 5 g L–1 yeast extract, and 5 g L–1
NaCl. LB-D solution was prepared by adding 50 mg L–1 DC to LB. Mineral medium (MM) was made of 1.5 g L–1 K2HPO4, 1.0 g L–1 NaCl, 0.5 g L–1
KH2PO4, 0.2 g L–1 MgSO4∙7H2O (pH = 7.0) (Leng et al., 2016). MM-D solution was prepared by supplementing MM with 50 mg L–1 DC. MM-T solution was prepared by supplementing MM with 10 g L–1 tryptone, and
MM-TD solution by supplementing MM-T with 50 mg L–1 DC.
2.2. Isolation and identification of degrading bacteria

Chicken litter samples were collected from a poultry facility in Henan
Province, China, where DC had been used for more than 5 years. First,
0.5 g chicken feces were added into 50 mL LB-D solution. The solution
was cultured at 30 °C and shaken at 150 rpm for 3 days in the dark.
Then, 20 μL enriched culture was serial diluted and streaked onto MMTD agar plates. The plates were then cultivated at 30 °C in dark for 3
days. Ten colonies with distinct shapes and colors were re-streaked on
MM-TD agar plates to obtain pure cultures. Based on biotransformation
performance, two bacterial strains DD1 and DD2 were selected for further analyses.
The phylogeny of DD1 and DD2 were determined using the phylogenetic analysis targeting the 16 S rRNA gene. Genomic DNA of two strains
were extracted using the Genomic DNA Extraction Kit (Axygen, USA) and
amplified using a PCR protocol targeting the 16S rRNA gene (Goodfellow and Stackebrandt, 1991). The PCR amplicons were purified and sequenced. The DNA sequences were searched against the GenBank database. Phylogenetic trees were built for DD1 and DD2 using ClustalX
1.8.3 with default settings.
2.3. DC biotransformation

Degradation experiments were carried out in batch reactors with 50 mL
solution. Based on preliminary experiments, the following four sets of

H e e t a l . i n J o u r n a l o f H a z a r d o u s M at e r i a l s 4 1 1 ( 2 0 2 1 )

5

experiments were designed: (1) different initial pH (i.e., 6.0, 7.0, 8.0, 9.0,
10.0) were conducted at 30 °C in MM-TD solutions; (2) different temperatures (i.e., 20, 25, 30, 35, 40 °C) were tested for DD1 at its optimal
initial pH of 7.0 and for DD2 at its optimal initial pH of 8.0 in MM-TD solutions; (3) different concentrations of tryptone (i.e., 2, 4, 6, 8, 10 g L–1)
were tested with an initial pH 7.0 at 20 °C for DD1 and pH 8.0 at 30 °C
for DD2 in MM-D solutions; (4) different initial DC concentrations (i.e.,
20, 50, 100, 150, 200 mg L–1) were tested at optimal conditions (i.e., pH
7.0, 10 g L–1 tryptone at 20 °C for DD1, and pH 8.0, 4 g L–1 tryptone at 30
°C for DD2). In all degradation experiments, 0.5 mL cell cultures (OD600
= 1) were added to MM-TD solution and the initial DC concentration was
50 mg L–1 unless noted otherwise. All experiments included triplicate
degradation reactors and triplicate no-cell control reactors and were
carried out in dark to prevent photo degradation.
2.4. Quantification of DC

1 mL liquid samples were periodically taken from the batch reactors and
were centrifuged at 8000 g for 10 min. The supernatants were amended
with McIlvaine-Na2EDTA buffer to chelate metal ions (Wu et al., 2011),
then filtered through 0.22 μm filter and stored at –20 °C. The concentration of DC was analyzed using high performance liquid chromatography
(HPLC, 1220 Infinity LC, Agilent, USA) with a C18 reverse column (4.6
mm × 150 mm, 5 μm, Agilent). Chromatographic conditions: the mobile
phase consisted of 0.1% oxalic acid - acetonitrile - methanol (67:22:11,
v:v:v) (Cinquina et al., 2003), flow rate 1 mL min–1, isocratic elution, column temperature 40 °C, injection volume 20 μL, and detection wavelength at 355 nm (Leng et al., 2016).
2.5. Identification of the transformation products

Three groups of samples were used to identify transformation products:
(1) solution from the no-cell control reactors on Day 0, (2) solution from
the no-cell control reactors on Day 3, and (3) solutions from the degradation reactors on Day 3. All samples were purified and concentrated
using the Oasis HLB (6cc/150 mg, Waters) solid phase extraction column (Leng et al., 2016; Wu et al., 2011).
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All transformation products were identified using liquid chromatography high resolution mass spectrometry (Q Exactive system, Thermo
scientific, USA). C18 reverse column (4.6 mm × 150 mm, 5 μm, Agilent)
was used as the chromatographic separation column with mobile phase
being 0.1% formic acid solution - acetonitrile - methanol (67:22:11,
v:v:v), flow rate being 0.3 mL min–1, isocratic elution time being 15 min,
and injection volume being 5 μL. Heated electrospray ionization (HESI)
source with a spray voltage of 3.5 kV was employed and the mass spectrometry was operated under positive ion mode. S-lens RF level was
set at 50%, capillary temperature at 300 °C, and collision energy at 35
eV. A full scan mode with m/z range of 200–600 was used for data acquisition. Xcalibur 2.1 software (Thermo Scientific) was used for mass
spectra analysis. The biotransformation products of DC were proposed
based on tandem quadrupole high resolution mass spectra: predicted
mass (m/z), measured mass (m/z), error between predicted vs measured masses (<5 ppm), elemental composition, and intensity. Disc diffusion test was conducted on the transformation products following the
protocol used in Leng et al. (2016).
2.6. Modeling

In control reactors DC reduction resulted from hydrolysis only, while
in treatment reactors DC reduction resulted from both hydrolysis and
biotransformation. First-order kinetics was used to describe the overall degradation process (Eq. 1) and hydrolysis process (Eq. 2) (Leng et
al., 2016). The difference between Eqs. (1) and (2) accounted for the DC
that was biotransformed (Eq. 3)
CHB = C0 – C0 × e–kHB×t

CH = C0 – C0 × e–kH×t

CB = CHB – CH = C0 × e–kH×t – C0 × e–kHB×t

(1)
(2)
(3)

where C0 is the initial concentration of DC, kH is the first-order reaction
rate constant (h–1) of the hydrolysis reaction process, and kHB is the firstorder reaction rate constant (h–1) of the overall degradation reaction (i.e.,
hydrolysis + biotransformation), CH is the concentration change of DC
due to hydrolysis only, CHB is the concentration change of DC due to both
hydrolysis and biotransformation, and CB is the concentration change of
DC due to biotransformation (mg L–1).
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The biotransformation of DC by DD2 was delayed for 24 h at pH 6
and 10 (Eq. 4). The biotransformation of DC by DD1 was delayed for 72
h at T = 40 °C and delayed by 24 h when tryptone concentration was 2
g L–1 (Eqs. 4, 5).
CB = C0 × e–kH×(t–24) – C0 × e–kHB×(t–24)
CB = C0 × e–kH×(t–72) – C0 × e–kHB×(t–72)

(4)
(5)

After taking the derivative on both sides of Eq. 3 over time, biotransformation rate VB (mg L–1 h–1, i.e., the rate of DC removal due to biotransformation) can be calculated as (Eq. 6).
VB = C0 × (kH × e–kH×t – kHB × e–kHB×t)

(6)

For the experiment with different initial DC concentrations, initial biotransformation rate at time 0 was used to examine if the experimental
data can be described using the Michaelis-Menten model (Eq. 7).
VB =

VB,max × S
Km + S

(7)

where VB is the initial biotransformation rate (h–1), VB,max is the maximum initial biotransformation rate (h–1), Km (mg L–1) is half saturation
constant, and S is the initial concentration of DC (mg L–1).
3. Results
3.1. Isolation and identification of strains

Ten bacterial strains were isolated from the chicken litter. Among the
ten strains, strain DD1 and DD2 exhibited faster DC biotransformation
kinetics and higher DC biotransformation efficiencies over the other
strains. According to the 16S rRNA gene sequence, strain DD1 and DD2
were identified as Brevundimonas naejangsanensis and Sphingobacterium mizutaii strains, respectively. The sequences of the 16S rRNA gene
of the two strains have been deposited under the accession numbers
MT809477 and MT809478 at GenBank. Further biotransformation studies were focused on these two strains.
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3.2. Characterization of DC biotransformation
Because DC hydrolyzes in water, DC biotransformation in solution cannot be directly measured. Hence, all experiments in this study included
treatment reactors that contained bacterial strain DD1 or DD2 and
control reactors that contained no cells. Only hydrolysis occurred in
the control reactors, while both hydrolysis and biotransformation occurred in the treatment reactors. The difference in DC concentrations
between the two experiments can be attributed to biotransformation.
Strain DD1 and strain DD2 could not grow in MM-D solutions (Fig. S1),
suggesting that neither strain could utilize DC as the sole carbon and
energy source. Therefore, an external carbon source, tryptone, was
added in subsequent experiments to facilitate DC biotransformation
through cometabolism.
Under optimal conditions both bacterial strains could degrade DC to
very low levels. After 216 h, the residual DC concentrations in the control and the treatment reactors containing B. naejangsanensis strain DD1
were 37.58 mg L–1 and 5.20 mg L–1, respectively (Fig. 1a). Similarly, after 48 h the residual DC concentrations in the control and treatment reactors containing S. mizutaii strain DD2 were 40.27 mg L–1 and 1.26 mg
L–1, respectively (Fig. 1b). Both hydrolysis and overall degradation can be
described using first order reaction kinetics. The kinetic equations (Eqs.
1–3) described the experimental data well (Fig. 1c and d) with R2 values ranging between 0.9826 and 0.9995. It was noticed that both strain
DD1 and DD2 formed biofilm on the inner wall of the reactors. Degradation experiments with autoclaved cells show that adsorption could account for 1.2% and 1.6% reduction in DC concentrations due to adsorption by DD1 and DD2, respectively. The relatively low adsorption of DC
was likely due to the surface properties and the concentrations of the
pure cultures in the reactors.
An experiment was conducted to determine if strains DD1 and DD2
could utilize substrates other than tryptone for DC biotransformation
through cometabolism (Fig. S2). DD1 showed some capability to biotransform DC when glucose, sucrose, or sodium acetate was used as
growth substrate. DD2 was able to biotransform DC when glucose or sucrose was used as growth substrate. For both strains, tryptone appeared
to perform superior or similar to the other substrates tested.
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Fig. 1. The residual concentrations of DC in experiments involving strain DD1 (a) and
DD2 (b) at the optimal conditions (20 °C, pH 7, 10 g L–1 tryptone for DD1; and 30 °C,
pH 8, 4 g L–1 tryptone for DD2). The actual and modeled concentrations of DC removed
by various mechanisms in experiments involving strain DD1 (c) and DD2 (d). Error
bars represent the standard deviations from triplicate experiments. Lines were modeled using Eqs. (1)–(3). The R2 values range between 0.9826 and 0.9970 (c), 0.9836–
0.9995 (d).

3.3. Effects of pH on DC biotransformation
Both hydrolysis and biotransformation of DC were significantly affected
by pH (Fig. 2). Hydrolysis rate constant kH was positively correlated with
initial pH (Fig. 2a and b inserts). For strains DD1 and DD2, the initial
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Fig. 2. The temporal changes of DC concentrations due to hydrolysis (a, b) and biotransformation (c, d) by strain DD1 (a, c) and DD2 (b, d) at different initial pHs. Lines
were modeled using Eqs. (2)–(4). Error bars represent the standard deviation from
triplicate experiments. The R2 values range between 0.9903 and 0.9993 (a), 0.9107–
0.9961 (b), 0.9880–0.9993 (c), 0.9788–0.9986 (d).

biotransformation rate reached the highest value at pH 7 for DD1 (VB
= 1.03 mg L–1 h–1) and pH 8 for DD2 (VB = 1.86 mg L–1 h–1). At the optimal pH, a maximum of 28.92 mg L–1 and 39.96 mg L–1 DC reduction was
attributed to biotransformation by DD1 and DD2, respectively (Fig. 2c
and d). In addition, the biotransformation of DC by DD2 was delayed
for about 24 h when the initial pH was 10. Because cells almost stopped
growing under initial pH 6, there was hardly any DC biotransformation
under this pH (Fig. 2d).
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Fig. 3. The temporal changes of DC concentrations due to hydrolysis (a, b) and biotransformation (c, d) by strain DD1 (a, c) and DD2 (b, d) at different temperatures. Lines
were modeled using Eqs. 2, 3 and 5. Error bars represent the standard deviation from
triplicate experiments. The R2 values range between 0.9559 and 0.9957 (a), 0.9731–
0.9974 (b), 0.9592–0.9910 (c), and 0.9990–0.9998 (d).

3.4. Effects of temperature on DC biotransformation
Within the temperature range tested (20–40 °C), temperature had moderate impacts on DC biotransformation by DD1 and DD2 (Fig. 3). Hydrolysis
rate constant (kH) increased with temperature (Fig. 3a and b inserts). The
highest initial biotransformation rate occurred at 30 °C for both strains
with the highest biotransformation rate being 1.05 mg L–1 h–1 for DD1 and
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Fig. 4. The temporal changes of DC concentrations due to hydrolysis (a, b) and biotransformation (c, d) by strain DD1 (a, c) and DD2 (b, d) at different initial tryptone
concentrations. Lines were modeled using Eqs. (2)–(4). Error bars represent the standard deviation from triplicate experiments. The R2 values range between 0.9650 and
0.9963 (a), 0.9561–0.9974 (b), 0.9716–0.9890 (c), and 0.996–0.9998 (d).

1.98 mg L–1 h–1 for DD2 (Fig. 3c and d inserts). A 72-h lag phase was observed in DD1 while the temperature was set at 40 °C (Fig. 3c).
3.5. Effects of tryptone concentration on DC biotransformation

The two strains responded differently to different initial tryptone concentrations (Fig. 4). The hydrolysis rate constant increased
with initial tryptone concentrations (Fig. 4a and b). For DD1, initial
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Fig. 5. The residual concentrations of DC by DD1 (a) and DD2 (b) at initial different
concentration DC. Lines were modeled using Eq. (7). Error bars represent the standard deviation from triplicate experiments. The values of R2 are 0.9669 and 0.9374.

biotransformation rate increased with initial tryptone concentrations
(Fig. 4c insert). When initial tryptone concentration was 10 g L–1, a maximum of 38.43 mg L–1 DC removal was attributed to biotransformation
with an initial biotransformation rate of VB = 0.82 mg L–1 h–1 (Fig. 4c). For
strain DD2, initial biotransformation rate decreased with initial tryptone concentrations (Fig. 4d insert). When the initial tryptone concentration was 2 g L–1, a maximum of 41.79 mg L–1 DC removal was attributed
to biotransformation with an initial biotransformation rate of VB = 2.34
mg L–1 h–1 (Fig. 4d). The biomass concentrations of DD1 and DD2 at the
end of the degradation experiments conducted under different pHs, temperatures, and initial tryptone concentrations are presented in Fig. S3.
3.6. Effects of initial DC concentrations

The Michaelis-Menten model could satisfactorily describe the biotransformation kinetics of DC. For DD1, cells growth ceased when the initial
DC concentrations were 150 and 200 mg L–1 (Fig. 5a). Non-linear regression on available data shows that VB,max and Km were 1.00 mg L–1 h–1 and
16.36 mg L–1, respectively, for the Michaelis-Menten equation. For DD2,
cell growth was inhibited when the initial DC concentrations were 100
mg L–1 and above (Fig. 5b). Non-linear regression analysis on the five
datum points show that VB,max and Km were 2.19 mg L–1h–1 and 49.85 mg
L–1, respectively.
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Fig. 6. The possible biotransformation pathway of DC by B. Naejangsanensis DD1 and
S. Mizutaii strain DD2.

3.7. Biotransformation products
Four and six biotransformation products were tentatively identified
from the biotransformation experiments with DD1 and DD2, respectively
(Table 1). The mass spectra, MS-MS fragmentation profile, proposed
fragmentation pattern of DC, and the biotransformation products (Fig.
S4–S29) were used to support the development of the biotransformation pathways (Fig. 6). There was a peak corresponding to the epimer
or isomer of DC at 0 h of the experiment (Figs. S4A and S15A) (Jutglar
et al., 2018; Leng et al., 2020).
In the biotransformation of DC by strain Brevundimonas naejangsanensis DD1, the parent compound DC was converted to the biotransformation product DP-417 following decarbonylation at C1 (Fig. 6). After
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Table1 Characteristics of the parent compound and the products from biotransformation of DC by B. naejangsanensis strain DD1 and S. mizutaii strain DD2.
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that, DP-417 went through deamination of the O˭C‒NH group outside C2
and became DP-402. DP-338 was formed by decarbonylation at the C2
position and dehydroxylation at C5 and C12a positions. DP- 338 was further converted to DP-323 by losing a methyl group from the ‒N‒(CH3)2
group at C4 to form DP-324 (uncaptured) and by substituting the hydroxyl group of C3 with ‒NH2.
In the biotransformation of DC by Sphingobacterium mizutaii DD2, the
parent compound DC was biotransformed through multiple pathways. In
the first pathway, DC was converted to DP-431 by losing a methyl group
from the N‒(CH3)2 group at C4. Further, DP-431 lost another methyl
group from the N-CH3 group at C4 to form DP-417 (uncaptured), which
lost two hydrogen ions at C4 and became DP-415. In parallel, DP- 431
may dehydrate at C5 to form DP-413(uncaptured), which lost two hydrogen ions at C4 to form DP-411. Through these two pathways, DP- 382
may form from DP-415 through deamination of the O˭C‒NH2 group outside C2 and dehydration at C5 or from DP-411 through demethylation
of the N‒CH3 group at C4 and deamination of the O˭C‒NH2 group outside C2. Finally, DP-403 may form from losing the carbonyl group at C1
of DP-431 or from losing the methyl group from the N‒(CH3)2 group at
C4 of DP-417.
3.8. Antimicrobial potency of transformation products

The biotransformation products of DD1 and DD2 exhibited lower antimicrobial potency than the parent compound DC and the products of
hydrolysis (Fig. 7). For the degradation with DD1, in the control reactors where only hydrolysis occurred, residual DC decreased from 50.00
mg L–1 to 37.58 mg L–1 at 216 h and the inhibition zone decreased from
19.5 mm to 15.0 mm. In the treatment reactor where both hydrolysis and
biotransformation occurred, the residual DC dropped from 50.00 mg L–1
to 5.20 mg L–1 at 216 h by DD1 and the inhibitory zone decreased from
19.4 mm to 8.3 mm. For the degradation with DD2, in the control reactors, residual DC dropped from 50.00 mg L–1 to 40.27 mg L–1 at 48 h, the
inhibition zone decreased from 19.5 mm to 17.9 mm. In the treatment
reactors where both hydrolysis and biotransformation occurred, the residual DC dropped from 50.00 mg L–1 to 1.26 mg L–1 at 48 h by DD2 and
the inhibitory zone decreased from 19.7 mm to 9.7 mm.
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Fig. 7. The antimicrobial potency of the degradation products as measured using inhibition zones and the concentration of residual DC of DD1 at 20 °C and initial pH 7, DD2
at 30 °C and initial pH 8. The inner diameter of the wells was 6 mm in the disk diffusion test. The error bars are standard deviations from triplicate experiments.

4. Discussion
4.1. Bacterial strains
This study reports two novel bacterial strains capable of biotransforming DC, Brevundimonas naejangsanensis DD1 and Sphingobacterium
mizutaii DD2. Previously, there was only one study that reported microbial degradation of DC using strains that belonged to Ochrobactrum,
Burkholderia, and Enterobacter (Wen et al., 2018). Brevundimonas has
been previously reported for its capability of degrading organic compounds such as antibiotic gentamicin (Liu et al., 2017) and fungicide
dimethachlon (Zhang et al., 2020). Enzyme aminoglycoside 3-acetyltransferase was speculated to be responsible for the biodegradation
of gentamicin in Brevundimonas (Liu et al., 2017). Similarly, Sphingobacterium also contained strains capable of degrading complex organic
compounds such as phenanthrene (Son et al., 2011) and chlorpyrifos
(Abraham and Silambarasan, 2013) with activities from enzymes like
catechol 2,3-dioxygenase and hydrolases. Brevundimonas naejangsanensis sp. occurs in soil (Kang et al., 2009), while Sphingobacterium
sp. have been isolated from soil and composts (Yoo et al., 2007; Choi
and Lee, 2012).
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It is worth noting that functional tet(X) gene has been reported in
both Sphingobacterium and Brevundimonas sp. strains (Ghosh et al.,
2014; Lu et al., 2019). The enzyme coded by tet(X) is a flavin-dependent monooxygenase, which can inactivate first and second generation
tetracyclines (Ian and Moore, 2005). A recent study showed that heterologous expression of tet(X) gene in E. coli can facilitate DC biodegradation (Wen et al., 2020) by regioselectively hydroxylating the C11a
of tetracycline substrate. The resulting unstable compound would then
undergo non-enzymatic decomposition (Yang et al., 2004). In this study,
both strains were tested positive for tet(X) using polymerase chain reaction (PCR), suggesting that the two strains have the genetic potential
to biotransform DC using the monooxygenase coded by tet(X).
4.2. Effects of pH and temperature on hydrolysis and biotransformation

DC is an amphiphilic molecule with three acid dissociation constants
(pKa = 3.50, 7.07, 9.13) and multiple ionizable functional groups (Bolobajev et al., 2016). There are cations, zwitterions and anions under different pH conditions. When the pH of the reaction solution increased
from 6 to 10, DC mainly existed in the form of zwitterions. Different reactive species with different degrees of ionization dominate the solution and lead to different hydrolysis rates (Chao et al., 2014; Herzog et
al., 2013). Biotransformation of DC by DD1 exhibited a downward trend
with time (Fig. 2c). We speculate that the presence of bacterial cells interfered with hydrolysis in the treatment reactors. In other words, the
hydrolysis process might have been slightly hindered by the bacterial
cells in the treatment reactor, making the hydrolysis in the cell-free control reactors an overestimation of the hydrolysis in the treatment reactors. This phenomenon was also observed in an earlier study where the
concentration of biotransformed tetracycline dipped slightly over time
(Leng et al., 2016).
4.3. Tryptone concentration

Tetracycline antibiotics may be biotransformed by pure bacterial strains
through cometabolism with tryptone (Leng et al., 2016), sucrose (Huang
et al., 2016), sodium acetate (Shao et al., 2018) as primary substrates.
DD1 and DD2 used tryptone as primary substrate to co-metabolize DC.
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During cometabolism, catabolic enzymes degrading non-growth substrate are produced in the process of utilizing growth substrate; hence,
growth substrate concentrations often affect the cometabolism of nongrowth substrate (Luo et al., 2008). DD1 and DD2 responded differently to background tryptone concentration (Fig. 4). Similar studies
have shown that different bacteria have different preferences for primary growth substrates. For example, when biotransforming tetracycline, Stenotrophomonas maltophilia DT1 had a higher biotransformation kinetics when both citrate and peptone were present as primary
growth substrates than when peptone was present alone (Leng et al.,
2016). The presence of glucose had an opposite effect to citrate (Leng et
al., 2017). According to a kinetic model for competitive cometabolism,
cometabolic transformation depends on the ratio of the initial growth
to nongrowth substrate concentration and the specificity constant ratio of growth to nongrowth substrates (Kim et al., 2020). Both strains
exhibited their dependence on the ratio of initial growth to nongrowth
substrate (Fig. 4). The different trends between the two strains shown
in Fig. 4 may be due to different specificity constant ratios of growth to
nongrowth substrates. Different specificities of DD1 and DD2 for DC, a
nongrowth substrate, might have determined how various initial concentrations of tryptone, a growth substrate, influence the amounts of
reducing power (i.e., the NADH needed for the oxidation of both growth
and nongrowth substrates when enzyme catalyzed reactions require molecular O2 as the terminal electron acceptor) diverted to DC oxidation.
4.4. Transformation products

Because the tetracycline compounds share similar structure, they share
similarity in their transformation pathways (Leng et al., 2016; Liu et al.,
2016). Between pH 6.5 and pH 9, during hydrolysis the decrease in DC
concentration was primarily due to conversion of DC to its isomer or
epimer with no other transformation products formed (Fig. S4A, S15A).
In contrast, biotransformation products were formed in the presence of
DD1 and DD2. Some biotransformation processes observed in this study
were similar to those observed in the biotransformation of other tetracycline compounds. For example, the demethylation reaction of the N(CH3)2 group at C4 and the decarbonylation reaction at C1 were also reported in a study where tetracycline was transformed by horseradish
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peroxidase (Leng et al., 2020). In the degradation of oxytetracycline, an
α-cleavage occurs at the C1-C12a bond, forming a diradical intermediate. The resulting diradical intermediate then loses a carbonyl group and
forms another diradical, which closes the ring (Liu et al., 2016). Similar transformation steps have been reported for tetracycline biotransformation by a Stenotrophomonas maltophilia strain (Leng et al., 2016).
The loss of the amide group from C2 (Fig. 6) also occurs during the
biotransformation of tetracycline by S. maltophilia (Leng et al., 2016), by
the gut microbiota in black soldier flies (Cai et al., 2018), and by biocatalyst laccase(de Cazes et al., 2014). This step was also proposed for tetracycline transformation by advanced oxidation (Jeong et al., 2010). The
phenomenon of demethylation at C4 was also observed in tetracycline
transformation by manganese oxide (Chen and Huang, 2011), laccase
(Yang et al., 2017), and S. maltophilia (Leng et al., 2016). The loss of –2
H at C4 to form C˭N also occurs during chloramination (Wan et al., 2013)
and biotransformation of the tetracycline compound (Leng et al., 2016).
DC differs in structure from tetracycline on the position of a hydroxyl
group (C5 of DC and C6 of tetracycline). Hence, reactions that happens
to the hydroxyl group on tetracycline cannot be transferred to DC. One
study reports that the hydroxyl group on C5 and the hydroxyl group on
C12a of DC may be lost in sequence through photocatalyst Ag/AgCl-CdMoO4 before a benzene ring is formed as a result of photocatalytic reaction (Wen et al., 2019).
5. Conclusions
In this study, B. naejangsanensis DD1and S. Mizutaii DD2 were characterized for their abilities to biotransform DC via cometabolism. The biotransformation kinetics were successfully modeled using a combination
of first-order kinetics. The effects of pH and temperature on the biotransformation kinetics were characterized. The two strains exhibited opposite trends in their DC biotransformation kinetics in response to increasing background tryptone concentrations. Finally, the biotransformation
pathways of DC by the two strains were proposed. Through a series of
demethylation, dehydration, and deamination, DC was converted to degradation products DP-323 and DP-382. The results from this study advanced our knowledge on DC biodegradability and generate qualitative
and quantitative information of DC biotransformation.
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S1

Figure S1. Neither DD1 nor DD2 could utilize DC as sole energy and carbon source. Residual DC
concentrations were measured 48 hours after the start of the experiment.

S2

Figure S2. The OD600 readings and the DC removal percentages of DD1 and DD2 at the end
of the degradation experiments (i.e., 7 days for DD1 and 2 days for DD2) with different
substrates. The experimental conditions were identical to those in Figure 1, except that the
concentrations for glucose, sucrose, sodium acetate, and tryptone were all set at 10 mg/L.

S3

Figure S3. The OD600 of DD1 and DD2 at the end of the degradation experiments conducted
under different (a) pHs, (b) temperatures, and (c) initial tryptone concentrations.

S4

S5

S6

Figure S4. Extracted ion chromatograms at (A) m/z 445, (B) m/z 417, (C) m/z 402, (D) m/z
338, (E) m/z 323 from the degradation experiment of DD1. Within each panel, the subpanel
from top to bottom represent initial DC parent compound on Day 0, degradation products
from hydrolysis and biotransformation on Day 3. The peaks were identified using mass
spectrometry.

S7

Figure S5. Mass spectrum of doxycycline (DC-445).

S8
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Figure S6. The secondary mass spectrometry (MS2) fragmentation profile and proposed
fragmentation pattern of DC-445.
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Figure S7. Mass spectrum of DP-417.
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Figure S8. The MS2 fragmentation profile and proposed fragmentation pattern of DP-417.
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Figure S9. Mass spectrum of DP-402.
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Figure S10. The MS2 fragmentation profile and proposed fragmentation pattern of DP-402.
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Figure S11. Mass spectrum of DP-338.
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Figure S12. The MS2 fragmentation profile of DP-338.
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Figure S13. Mass spectrum of DP-323.

S16

340

360

380

400

420

－CO
－H2O

Figure S14. The MS2 fragmentation profile and proposed fragmentation pattern of DP-323.
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Sphingobacterium mizutaii DD2
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Figure S15. Extracted ion chromatograms at (A) m/z 445, (B) m/z 431, (C) m/z 417, (D) m/z
415, (E) m/z 411, (F) m/z 403, (G) m/z 382 from the degradation experiments of DD2. Within
each panel, the ion chromatograms from top to bottom represent initial DC parent compound
on Day 0, degradation products from hydrolysis and from biotransformation on Day 3. The
peaks were identified using mass spectrometry.
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Figure S16. Mass spectrum of doxycycline.

S22

－H2O

－NH3

Figure S17. The MS2 fragmentation profile and proposed fragmentation pattern of DC-445.

S23

data4 #803 RT: 3.31 AV: 1 NL: 5.20E8
T: FTMS + p ESI Full ms [200.00-600.00]

35000000

Relative Abundance

30000000

25000000

20000000

15000000
431.14505

346.00894
10000000

5000000

0
280

293.09738

300.20132
315.07925
300

320

327.20105
340

417.16528
410.12213
354.01074
367.99078 381.98642 399.15588
360
m/z

Figure S18. Mass spectrum of DP-431.
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Figure S19. The MS2 fragmentation profile and proposed fragmentation pattern of DP-431.
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Figure S20. Mass spectrum of DP-417.
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Figure S21. The MS2 fragmentation profile and proposed fragmentation pattern of DP-417.
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Figure S22. Mass spectrum of DP-415
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Figure S23. The MS2 fragmentation profile and proposed fragmentation pattern of DP-415.
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Figure S24. Mass spectrum of DP-411.
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Figure S25. The MS2 fragmentation profile and proposed fragmentation pattern of DP-411.
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Figure S26. Mass spectrum of DP-403.
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Figure S27. The MS2 fragmentation profile and proposed fragmentation pattern of DP-403.
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Figure S28. Mass spectrum of DP-382.
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Figure S29. The MS2 fragmentation profile and proposed fragmentation pattern of DP-382.
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